Headache

New Daily Persistent Headache (NDPH)

NDPH ยท G44.52

New daily persistent headache (NDPH) is a primary headache disorder that begins abruptly and persists daily from onset, often occurring after a viral illness, with characteristically poor response to treatment.

2026-03-28

At a Glance

NDPH is defined by daily headache from onset that persists without remission for more than 3 months. Patients typically remember the exact date of onset. Unlike chronic migraine or chronic tension-type headache, NDPH is daily from the start without gradual progression. Post-infectious onset is common (30-50%), suggesting autoimmune or neuroinflammatory mechanisms. Two subtypes exist: self-limiting (resolving within months) and refractory (persisting for years). No single treatment shows consistent efficacy. Multi-modal approaches including preventive medications, nerve blocks, and behavioral strategies are typically employed.

Definition and Overview

New daily persistent headache (NDPH) is a primary headache disorder defined by daily headache from the moment of onset, persisting without remission for more than 3 months. Patients typically remember the exact date their headache started [1].

Unlike chronic migraine or chronic tension-type headache that evolve gradually, NDPH is daily from its inception. Post-infectious onset is common (30-50%), suggesting autoimmune or neuroinflammatory mechanisms [2].

Subtypes

Self-limiting subtype: resolves spontaneously within several months without specific treatment.

Refractory subtype: persists for years despite multiple treatment attempts. This subtype is notoriously treatment-resistant [3].

Diagnosis

ICHD-3 criteria: persistent headache, daily from onset, lasting more than 3 months, with clearly remembered onset or onset in less than 3 days. Not better accounted for by another headache disorder [1].

Secondary causes must be excluded: low/high CSF pressure headache, cerebral venous thrombosis, medication overuse. MRI with gadolinium and MR venography may be needed.

Treatment

No single treatment shows consistent efficacy. Multimodal approaches include preventive medications (topiramate, gabapentin, amitriptyline), nerve blocks (greater occipital nerve block), muscle relaxants, and behavioral strategies [4]. CGRP monoclonal antibodies are being explored. Doxycycline has shown benefit in cases with inflammatory features.

Frequently Asked Questions

FAQ content is being prepared.

References

  1. [1] Robbins MS, Grosberg BM, Napchan U, Crystal SC, Lipton RB (2010). "Clinical and prognostic subforms of new daily-persistent headache." Neurology, 74: 1358-1364. DOI PubMed
  2. [2] Headache Classification Committee of the International Headache Society (2018). "The International Classification of Headache Disorders, 3rd edition." Cephalalgia, 38: 1-211. DOI PubMed
  3. [3] Li D, Rozen TD (2002). "The clinical characteristics of new daily persistent headache." Cephalalgia, 22: 66-69. DOI PubMed
  4. [4] Prakash S, Shah ND (2010). "Post-infectious new daily persistent headache may be caused by a vascular mechanism." Cephalalgia, 30: 1035-1043. DOI PubMed
  5. [5] Mack KJ (2004). "New daily persistent headache in children and adults." Current Pain and Headache Reports, 8: 317-322. DOI PubMed
NDPHnew daily persistent headachechronic headachedaily headachetreatment-resistantpost-infectious

This content is provided for medical informational purposes only and cannot replace professional medical advice. If you have symptoms, please consult a specialist.

Are you concerned about related symptoms?

Get an accurate diagnosis at OSANG Neurosurgery.